851 related articles for article (PubMed ID: 19238142)
21. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
Onat A; Can G; Hergenç G
Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050
[TBL] [Abstract][Full Text] [Related]
22. Lifestyle variables, non-traditional cardiovascular risk factors, and the metabolic syndrome in an Aboriginal Canadian population.
Liu J; Young TK; Zinman B; Harris SB; Connelly PW; Hanley AJ
Obesity (Silver Spring); 2006 Mar; 14(3):500-8. PubMed ID: 16648622
[TBL] [Abstract][Full Text] [Related]
23. Serum uric acid is a determinant of metabolic syndrome in a population-based study.
Onat A; Uyarel H; Hergenç G; Karabulut A; Albayrak S; Sari I; Yazici M; Keleş I
Am J Hypertens; 2006 Oct; 19(10):1055-62. PubMed ID: 17027827
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
25. Plasma adiponectin distribution in a Mediterranean population and its association with cardiovascular risk factors and metabolic syndrome.
Salas-Salvadó J; Granada M; Bulló M; Corominas A; Casas P; Foz M
Metabolism; 2007 Nov; 56(11):1486-92. PubMed ID: 17950098
[TBL] [Abstract][Full Text] [Related]
26. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834
[TBL] [Abstract][Full Text] [Related]
27. Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study.
Saltevo J; Vanhala M; Kautiainen H; Kumpusalo E; Laakso M
Diabet Med; 2008 Jun; 25(6):747-50. PubMed ID: 18435780
[TBL] [Abstract][Full Text] [Related]
28. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men.
Seino Y; Hirose H; Saito I; Itoh H
Metabolism; 2007 Nov; 56(11):1493-9. PubMed ID: 17950099
[TBL] [Abstract][Full Text] [Related]
29. Association between mild renal dysfunction and insulin resistance or metabolic syndrome in a random nondiabetic population sample.
Onat A; Hergenç G; Uyarel H; Ozhan H; Esen AM; Karabulut A; Albayrak S; Can G; Keleş I
Kidney Blood Press Res; 2007; 30(2):88-96. PubMed ID: 17347575
[TBL] [Abstract][Full Text] [Related]
30. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
[TBL] [Abstract][Full Text] [Related]
31. Factors accounting for high ferritin levels in obesity.
Lecube A; Hernández C; Pelegrí D; Simó R
Int J Obes (Lond); 2008 Nov; 32(11):1665-9. PubMed ID: 18779821
[TBL] [Abstract][Full Text] [Related]
32. Metabolic syndrome and C-reactive protein among cardiology patients.
Chapidze G; Dolidze N; Enquobahrie DA; Kapanadze S; Latsabidze N; Williams MA
Arch Med Res; 2007 Oct; 38(7):783-8. PubMed ID: 17845899
[TBL] [Abstract][Full Text] [Related]
33. Association of adiponectin with procollagen type I carboxyterminal propeptide in non-diabetic essential hypertension.
Tsai WC; Lin CC; Chen JY; Huang YY; Lee CH; Li WT; Weng CM; Chen JH
Blood Press; 2008; 17(4):233-8. PubMed ID: 18671144
[TBL] [Abstract][Full Text] [Related]
34. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
[TBL] [Abstract][Full Text] [Related]
35. Adiponectin and insulin sensitivity in primary aldosteronism.
Fallo F; Della Mea P; Sonino N; Bertello C; Ermani M; Vettor R; Veglio F; Mulatero P
Am J Hypertens; 2007 Aug; 20(8):855-61. PubMed ID: 17679033
[TBL] [Abstract][Full Text] [Related]
36. Serum sex-hormone-binding globulin is related to hepatic and peripheral insulin sensitivity but not to beta-cell function in men and women with Type 2 diabetes mellitus.
Laing I; Olukoga AO; Gordon C; Boulton AJ
Diabet Med; 1998 Jun; 15(6):473-9. PubMed ID: 9632121
[TBL] [Abstract][Full Text] [Related]
37. Gender difference among smoking, adiponectin, and high-sensitivity C-reactive protein.
Ahonen TM; Kautiainen HJ; Keinänen-Kiukaanniemi SM; Kumpusalo EA; Vanhala MJ
Am J Prev Med; 2008 Dec; 35(6):598-601. PubMed ID: 18842390
[TBL] [Abstract][Full Text] [Related]
38. Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans.
Lyoussi B; Ragala MA; Mguil M; Chraibi A; Israili ZH
Clin Exp Hypertens; 2005 May; 27(4):377-94. PubMed ID: 15921074
[TBL] [Abstract][Full Text] [Related]
39. Metabolic syndrome is not associated with markers of subclinical atherosclerosis, serum adiponectin and endogenous androgen concentrations in Japanese men with Type 2 diabetes.
Fukui M; Ose H; Kitagawa Y; Kamiuchi K; Nakayama I; Ohta M; Obayashi H; Yamasaki M; Hasegawa G; Yoshikawa T; Nakamura N
Diabet Med; 2007 Aug; 24(8):864-71. PubMed ID: 17593243
[TBL] [Abstract][Full Text] [Related]
40. Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects.
Saadi H; Nagelkerke N; Carruthers SG; Benedict S; Abdulkhalek S; Reed R; Lukic M; Nicholls MG
Diabetes Res Clin Pract; 2008 Jun; 80(3):392-8. PubMed ID: 18282631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
